Literature DB >> 6203101

99mTc-aprotinin: comparison with 99mTc-DMSA in normal and diseased kidneys.

C Aprile, R Saponaro, G Villa, F Lunghi.   

Abstract

Aprotinin (A) and DMSA labelled with 99mTc were compared in patients with normal (NK, n = 12) and diseased kidneys (CRF, n = 13) by means of quantitative serial scans and measurements of blood clearance and urinary excretion. Serial scans only were obtained in additional 13 patients. Scan quality in the NK patients was essentially equal: faster blood clearances, reduced urinary excretions and higher fixations of A in the target compensated for the increased liver uptake. On the other hand, the scan quality in the CRF patients was definitely superior with A, allowing detection of residual functioning parenchyma also in severe kidney failure. Correlation between the net kidney uptake 6 hrs p.i. and the separate hippuran clearance rate was better with A than with DMSA, indicating the feasibility of A in evaluating relative renal function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203101

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  3 in total

1.  Assessment of split renal function with 99mTc-aprotinin.

Authors:  C Aprile; R Saponaro; G Villa; M Carena; F Lunghi; S B Solerte; A Salvadeo
Journal:  Eur J Nucl Med       Date:  1986

2.  Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin.

Authors:  C Aprile; G Marinone; R Saponaro; C Bonino; G Merlini
Journal:  Eur J Nucl Med       Date:  1995-12

Review 3.  A Narrative Review of 99mTc-Aprotinin in the Diagnosis of Cardiac Amyloidosis and a New Life for an Unfairly Abandoned Drug.

Authors:  Carlo Aprile; Lorenzo Lodola
Journal:  Biomedicines       Date:  2022-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.